{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:34:21Z","timestamp":1793698461518,"version":"4.5.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We conducted a systematic review of randomized, controlled trials (RCTs) to generate more precise estimates of the efficacy and safety of oral versus intravenous antibiotic therapy for Staphylococcus aureus bacteremia or endocarditis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>MEDLINE, Embase, the Cochrane Library, and Web of Science databases were searched through February 2024. RCTs were included if they compared oral versus intravenous antibiotic therapy for S. aureus bacteremia or endocarditis and appropriately reported outcomes for each group. Risk of bias was assessed using the revised Cochrane tool for assessing risk of bias in randomized trials. Heterogeneity between studies was evaluated with Cochran's Q-statistic and I2 test. Treatment effects were summarized with pooled risk ratios using a random effects model meta-analysis (PROSPERO CRD42024481512).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Only four RCTs met criteria for inclusion in meta-analysis. Among participants assessed for treatment failure, there was no difference between oral and intravenous therapy groups (risk ratio [RR], 0.99; 95% confidence interval [CI], .63\u20131.57; I2 = 0%). There was also no significant difference in adverse events between oral and intravenous therapy groups (RR, 0.65; 95% CI, .07\u20135.94; I2 = 74%); however, the confidence interval was wide, and heterogeneity was high.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this systematic review of RCTs comparing oral with intravenous antibiotic therapy for S. aureus bacteremia or endocarditis, few studies met the eligibility criteria for inclusion. Meta-analysis of these studies suggests that transitioning from intravenous to oral therapy is likely effective in a subgroup of carefully selected patients. Additional randomized trials are necessary before transition to oral therapy can be routinely recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciae476","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T16:29:41Z","timestamp":1726504181000},"page":"29-36","source":"Crossref","is-referenced-by-count":20,"title":["Oral Versus Intravenous Antibiotic Therapy for\n                    <i>Staphylococcus aureus<\/i>\n                    Bacteremia or Endocarditis: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3149-597X","authenticated-orcid":false,"given":"Ahmad","family":"Mourad","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Duke University Medical Center , Durham, North Carolina ,","place":["USA"]},{"name":"Duke Clinical Research Institute , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nnamdi","family":"Nwafo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Colorado Anschutz Medical Campus , Aurora, Colorado ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Skalla","sequence":"additional","affiliation":[{"name":"Duke University Medical Center Library & Archives, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L","family":"Holland","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Duke University Medical Center , Durham, North Carolina ,","place":["USA"]},{"name":"Duke Clinical Research Institute , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Denver Health , Denver, Colorado ,","place":["USA"]},{"name":"Department of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine , Aurora, Colorado ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"2025020710472462200_ciae476-B1","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","article-title":"Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis","volume":"28","author":"Bai","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2025020710472462200_ciae476-B2","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2025020710472462200_ciae476-B3","doi-asserted-by":"crossref","first-page":"ofy132","DOI":"10.1093\/ofid\/ofy132","article-title":"Infectious diseases physicians\u2019 perspectives regarding injection drug use and related infections, United States, 2017","volume":"5","author":"Rapoport","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2025020710472462200_ciae476-B4","doi-asserted-by":"crossref","first-page":"ofaa151","DOI":"10.1093\/ofid\/ofaa151","article-title":"A narrative review of early oral stepdown therapy for the treatment of uncomplicated Staphylococcus aureus bacteremia: yay or nay?","volume":"7","author":"Dagher","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2025020710472462200_ciae476-B5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cmi.2019.05.012","article-title":"Transition from intravenous to oral antimicrobial therapy in patients with uncomplicated and complicated bloodstream infections","volume":"26","author":"Al-Hasan","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2025020710472462200_ciae476-B6","doi-asserted-by":"crossref","first-page":"e02345-19","DOI":"10.1128\/AAC.02345-19","article-title":"Efficacy of early oral switch with beta-lactams for low-risk Staphylococcus aureus bacteremia","volume":"64","author":"Bupha-Intr","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2025020710472462200_ciae476-B7","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/cid\/ciad119","article-title":"Real-world application of oral therapy for infective endocarditis: a multicenter, retrospective, cohort study","volume":"77","author":"Freling","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025020710472462200_ciae476-B8","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1093\/cid\/ciaa365","article-title":"Evaluation of partial oral antibiotic treatment for persons who inject drugs and are hospitalized with invasive infections","volume":"71","author":"Marks","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025020710472462200_ciae476-B9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jamainternmed.2020.0555","article-title":"Evaluation of a paradigm shift from intravenous antibiotics to oral step-down therapy for the treatment of infective endocarditis: a narrative review","volume":"180","author":"Spellberg","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2025020710472462200_ciae476-B10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3947\/ic.2014.46.3.172","article-title":"Oral antimicrobial therapy: efficacy and safety for methicillin-resistant Staphylococcus aureus infections and its impact on the length of hospital stay","volume":"46","author":"Yoon","year":"2014","journal-title":"Infect Chemother"},{"key":"2025020710472462200_ciae476-B11","doi-asserted-by":"crossref","first-page":"106329","DOI":"10.1016\/j.ijantimicag.2021.106329","article-title":"Comparison of linezolid step-down therapy to standard parenteral therapy in methicillin-resistant Staphylococcus aureus bloodstream infections","volume":"57","author":"Yeager","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"2025020710472462200_ciae476-B12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/cid\/ciad666","article-title":"Early oral antibiotic switch in Staphylococcus aureus bacteraemia: the Staphylococcus aureus network adaptive platform (SNAP) trial early oral switch protocol","volume":"79","author":"de Kretser","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025020710472462200_ciae476-B13","author":"Higgins"},{"key":"2025020710472462200_ciae476-B14","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025020710472462200_ciae476-B15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2025020710472462200_ciae476-B16","author":"Covidence systematic review software"},{"key":"2025020710472462200_ciae476-B17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jclinepi.2020.11.003","article-title":"Machine learning reduced workload with minimal risk of missing studies: development and evaluation of a randomized controlled trial classifier for Cochrane reviews","volume":"133","author":"Thomas","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"2025020710472462200_ciae476-B18","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2025020710472462200_ciae476-B19","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1002\/sim.1009","article-title":"A refined method for the meta-analysis of controlled clinical trials with binary outcome","volume":"20","author":"Hartung","year":"2001","journal-title":"Stat Med"},{"key":"2025020710472462200_ciae476-B20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2025020710472462200_ciae476-B21","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jclinepi.2014.11.023","article-title":"Grading the strength of a body of evidence when assessing health care interventions: an EPC update","volume":"68","author":"Berkman","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"2025020710472462200_ciae476-B22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0002-9343(96)00070-8","article-title":"Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy","volume":"101","author":"Heldman","year":"1996","journal-title":"Am J Med"},{"key":"2025020710472462200_ciae476-B23","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/424506","article-title":"A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection","volume":"39","author":"Schrenzel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2025020710472462200_ciae476-B24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N Engl J Med"},{"key":"2025020710472462200_ciae476-B25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1473-3099(23)00756-9","article-title":"Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial","volume":"24","author":"Kaasch","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025020710472462200_ciae476-B26","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/cid\/ciac177","article-title":"How generalizable are randomized controlled trials (RCTs) in Staphylococcus aureus bacteremia? A description of the mortality gap between RCTs and observational studies","volume":"75","author":"Bai","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025020710472462200_ciae476-B27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/infdis\/jiac219","article-title":"Heterogeneity in Staphylococcus aureus bacteraemia clinical trials complicates interpretation of findings","volume":"226","author":"Dolby","year":"2022","journal-title":"J Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae476\/59962335\/ciae476.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/1\/29\/59962335\/ciae476.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/1\/29\/59962335\/ciae476.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T05:47:35Z","timestamp":1738907255000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/80\/1\/29\/7759901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,9,18]]},"published-print":{"date-parts":[[2025,2,5]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae476","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1,15]]},"published":{"date-parts":[[2024,9,18]]}}}